Latham & Watkins advised Epiris on the transaction. Fastmarkets announced that it has completed the planned demerger from Delinian, formerly known as Euromoney Institutional Investor plc and...
You must be a Standard 1 Year member to access this content.
Willkie Farr advised the Lifeways Group, and Latham & Watkins advised the senior secured lenders. On February 22, the English High Court sanctioned restructuring plans under...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison LLP and Macfarlanes advised KPS, while Latham & Watkins LLP advised Princess Yachts on the deal. KPS Capital Partners announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Foot Anstey have advised L Catterton Europe on the deal. Joelson has advised the Co-Founders of Little Moons. L Catterton Europe, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Mesoblast in the transaction. Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in stem cell medicines for inflammatory diseases, has announced that it has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...
You must be a Standard 1 Year member to access this content.
